Human Somatostatin SST₄ Receptor Transgenic Mice: Construction and Brain Expression Pattern Characterization

• Main Authors: Balázs Nemes, Kata Bölcskei, Angéla Kecskés, Viktória Kormos, Balázs Gaszner, Timea Aczél, Dániel Hegedüs, Erika Pintér, Zsuzsanna Helyes, Zoltán Sándor
• Format: Article
• Language: English
• Published: MDPI AG 2021-04-01
• Series: International Journal of Molecular Sciences
• Subjects: somatostatin; <i>Sstr4</i> KO mice; <i>SSTR4</i> humanized mice; PiggyBac (PB) transposon vector; ligation-mediated PCR; RNAscope in situ hybridization
• Online Access: https://www.mdpi.com/1422-0067/22/7/3758

Somatostatin receptor subtype 4 (SST₄) has been shown to mediate analgesic, antidepressant and anti-inflammatory functions without endocrine actions; therefore, it is proposed to be a novel target for drug development. To overcome the species differences of SST₄ receptor expression and function between humans and mice, we generated an SST₄ humanized mouse line to serve as a translational animal model for preclinical research. A transposon vector containing the <i>hSSTR4</i> and reporter gene construct driven by the <i>hSSTR4</i> regulatory elements were created. The vector was randomly inserted in <i>Sstr4</i>-deficient mice. <i>hSSTR4</i> expression was detected by bioluminescent in vivo imaging of the luciferase reporter predominantly in the brain. RT-qPCR confirmed the expression of the human gene in the brain and various peripheral tissues consistent with the in vivo imaging. RNAscope in situ hybridization revealed the presence of <i>hSSTR4</i> transcripts in glutamatergic excitatory neurons in the CA1 and CA2 regions of the hippocampus; in the GABAergic interneurons in the granular layer of the olfactory bulb and in both types of neurons in the primary somatosensory cortex, piriform cortex, prelimbic cortex and amygdala. This novel SST₄ humanized mouse line might enable us to investigate the differences of human and mouse SST₄ receptor expression and function and assess the effects of SST₄ receptor agonist drug candidates.